Glasgow Business . 29
www.glasgowchamberofcommerce.com Te centre will be located in the University
of Glasgow and NHS Greater Glasgow & Clyde’s new learning and teaching facility on the South Glasgow Hospitals campus where it will be linked physically to the planned Clinical Research Facility for stratified clinical trials. Professor Dominiczak said: “Researchers
will benefit from access to sequenced human genomes combined with clinical data, enabling world-leading developments in stratified medicine in chronic diseases.” Te funding of the centre marks the degree
of wide collaboration involved in the project. Te Scotish Funding Council is providing £8 million over five years, with the consortium behind the centre having also already secured a commitment of £2 million in cash and £4.6 million in kind in investment for the project from business partners including SMEs. Te key business partners are Life Technologies and Aridhia. Peter Silvester, President Europe, Middle
East & Africa of Life Technologies, said: “Te Stratified Medicine Scotland Innovation Centre is a groundbreaking project that represents a real opportunity to change the way healthcare will be practised. “Life Technologies will provide facilities
and the genetic analysis platform with its semiconductor-based Ion Proton DNA sequencing technology at a speed, accuracy and cost that would have been impossible just a few months ago. “Te vision for this project is to combine
an individual’s detailed genomic data with more traditional patient information to enable faster, more accurate and effective clinical decisions. Tis is an inflection point in the history of medical research, and there is much more to come.” An independent economic impact
assessment forecast that the centre could generate up to 334 jobs and up to £68 million to the Scotish economy over its initial five-year funding period. Te Centre aims to atract sufficient research sponsorship from industry partners to allow it to become self-sustaining within five years. Professor Dominiczak said: “We have a
Professor Anna Dominiczak, Vice-Principal and Head of College of Medical, Veterinary and Life Sciences, University of Glasgow
of the three Schools – the School of Life Sciences, the School of Veterinary Medicine and the School of Medicine, which includes Dentistry and Nursing. It also includes seven institutes for research,
headed up by leading scientists: Cancer Sciences; Cardiovascular and Medical Sciences; Biodiversity, Animal Health and Comparative Medicine; Infection, Immunity and Inflammation; Molecular, Cell and Systems Biology; Neuroscience and Psychology; and Health and Wellbeing. Professor Dominiczak said: “All of these are
open for industrial collaboration, something that perhaps was underplayed in the past but is extremely important for the local economy.” She said that Scotland now has a unique
”We have a very big ambition here which is to transform the management of chronic disease globally ... the right treatment to the right patient at the right cost”
very big ambition here which is to transform the management of chronic disease globally by accelerating biomedical research, high equality health care provision and economic growth.” She said there were a lot of potential ‘wins’
from the work of the centre and the wider health and life sciences sector: improving treatment and therefore the health of patients, cuting the NHS drug bill by excluding payments for wrong treatments and the resulting jobs and economic growth. She said: “Te centre’s central mission is to
provide the right treatment to the right patient at the right cost.” Professor Dominiczak heads up the
University of Glasgow’s College of Medical, Veterinary and Life Sciences, which is made up
selling proposition in the health and life sciences area with the combination of the NHS as health provider, Life Technologies providing the genetics input and Aridhia (run by experienced and successful Scotish entrepreneur David Sibbald) providing the IT analytics. Tese commercial partners are part of a
much broader health and life sciences sector in Glasgow and the West of Scotland. Te Glasgow Economic Leadership
Board, which is facilitated by Glasgow Chamber, is working to promote a bio corridor which it hopes will act as a magnet for future investment. At one end of the bio corridor is the
BioCity Scotland incubation centre in the former Merck pharma factory at Newhouse on the M8, which provides more than 130,000 square feet of high spec chemistry and biology labs plus office space. At the other end of the bio corridor is the
GlaxoSmithKline facility in Irvine in Ayrshire with the Life Technologies base at Inchinnan in Renfrewshire and all that Glasgow city has to offer in between. Past investment in Scotland in electronic
health records and translational medical research, coupled with a vibrant healthcare technology industry and the focus of this latest work, means Glasgow and West Central Scotland can be at the global forefront of this field.
Artist’s impressions of the new Stratified Medicine Scotland Innovation Centre
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52